OriBase Pharma is the result of the merger between Nova Decision and Azasynth. In 2010, the two companies joined forces in new headquarters in Montpellier, France. Before the merger, both companies were young biotech start-ups, created in 2007.
OriBase Pharma is an international oriented contract research organization (CRO) serving many countries around the world, and we are continuously broadening our international reach; aiming for a global footprint.
Today, OriBase Pharma consists of 15 employees: 11 within R&D and 4 within Business Development and Administration.